Cereno Scientific AB: Funding, Investors & Team (Sep 2026)
Cereno Scientific is a clinical stage biotech company within cardiovascular diseases. The lead drug candidate, CS1, is a Phase II candidate in development for the treatment of the rare disease pulmonary arterial hypertension (PAH) and thrombotic indications. CS1 is an HDAC (Histone DeACetylase) inhibitor that acts as an epigenetic modulator with anti-thrombotic, anti-inflammatory, anti-fibrotic and pressure-relieving properties, all relevant for PAH. In addition, Cereno has two promising preclinical development programs targeted at treating cardiovascular diseases. The company is headquartered in AstraZeneca’s BioVenture Hub, Sweden, and has a US subsidiary Cereno Scientific Inc. based in Kendall Square in Boston, Massachusetts, US. Cereno is listed on the Nasdaq First North (CRNO B). More information on www.cerenoscientific.com.
Cereno Scientific AB has raised $38.3M across 3 funding rounds on record, the most recent an undisclosed round of $7.8M announced in Jun 2025.
That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Cereno Scientific AB Company Profile and Key Stats
Latest funding round on record: Jun 2025.
Cereno Scientific AB Funding Rounds
Cereno Scientific AB raised $7.4M in an undisclosed round announced in Mar 2024.
8 months later, an undisclosed round of $23.1M was announced in Nov 2024.
7 months later, an undisclosed round of $7.8M was announced in Jun 2025.
Cereno Scientific AB Founders and Leadership Team
No contact details are on record for this team yet.
Cereno Scientific AB Funding Compared to Other Health Care Startups
Cereno Scientific AB's latest round of $7.8M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Cereno Scientific AB in Health Care and Mölndal
Companies Similar to Cereno Scientific AB
Neko Health, a health-tech company from Sweden, aims to develop a healthcare system that promotes the…
Celluminova specializes in the development of new tools for stem cell research, including cancer stem cells.
Klaria (Klaria Pharma Holding AB) is a Swedish listed pharmaceutical company that develops innovative,…
ChemoTech is a Scandinavian company based at Medicon Village in Lund, Sweden. The company’s founders have…
Spermosens is a medical equipment manufacturer that produces technologies for diagnosing male-factor…
IRLAB is a Swedish drug discovery and development company providing novel treatments for disorders of the…
The AlzeCure Foundation is focused on the development of novel diagnostics and therapeutics for PD, AD and…
Blodtrycksdoktorn is an evidence-based digital innovation that uses telemedicine, mobile health technology,…
B! BB Instruments develops an instrument that allows quick and easy sampling of suspected cancer tumors by…
Observe Medical has developed a revolutionary digital urine meter - Sippi. Sippi is an easy-to-use…
Beactica Therapeutics AB is a precision oncology company committed to the fight against cancer. The company…
Loovi is a health technology firm that provides a doctor-led, data-driven longevity solution. It focuses on…
Cereno Scientific AB Funding FAQs
What does Cereno Scientific AB do?
Cereno Scientific is a clinical stage biotech company within cardiovascular diseases. The lead drug candidate, CS1, is a Phase II candidate in development for the treatment of the rare disease pulmonary arterial hypertension (PAH) and thrombotic indications. CS1 is an HDAC (Histone DeACetylase) inhibitor that acts as an epigenetic modulator with anti-thrombotic, anti-inflammatory, anti-fibrotic and pressure-relieving properties, all relevant for PAH. In addition, Cereno has two promising preclinical development programs targeted at treating cardiovascular diseases. The company is headquartered in AstraZeneca’s BioVenture Hub, Sweden, and has a US subsidiary Cereno Scientific Inc. based in Kendall Square in Boston, Massachusetts, US. Cereno is listed on the Nasdaq First North (CRNO B). More information on www.cerenoscientific.com.
How much funding has Cereno Scientific AB raised?
Cereno Scientific AB has raised $38.3M across 3 rounds on record. The most recent is an undisclosed round of $7.8M announced in Jun 2025.
When did Cereno Scientific AB last raise funding?
Cereno Scientific AB's most recent funding round on record is an undisclosed round of $7.8M, announced in Jun 2025.
Who founded Cereno Scientific AB?
FundedIQ lists Pia Larsson (Founder) at Cereno Scientific AB.
Where is Cereno Scientific AB headquartered?
Cereno Scientific AB is based in Mölndal, Vastra Gotaland, Sweden.
How many employees does Cereno Scientific AB have?
Cereno Scientific AB is in the 1-10 employee band.
How does Cereno Scientific AB's funding compare to other Health Care startups?
Cereno Scientific AB's latest round of $7.8M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Cereno Scientific AB Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cereno Scientific AB is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.